Gilpin Andrea, Bérubé Sophie, Moore-Hepburn Charlotte, Lacaze-Masmonteil Thierry, Samiee-Zafarghandy Samira, Rieder Michael, Gruenwoldt Emily, MacLeod Stuart, Litalien Catherine
The Rosalind & Morris Goodman Family Pediatric Formulations Centre of the Centre Hospitalier Universitaire (CHU) Ste-Justine (Gilpin [at the time of article submission], Bérubé, Litalien), Montréal, Que.; Health Canada (Gilpin), Ottawa, Ont.; Department of Pediatrics (Moore-Hepburn), University of Toronto, Toronto, Ont.; Section of Neonatology (Lacaze-Masmonteil), Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alta.; Division of Neonatology (Samiee-Zafarghandy), Department of Pediatrics, McMaster Children's Hospital, McMaster University, Hamilton, Ont.; Division of Pediatric Clinical Pharmacology (Rieder), Department of Pediatrics, University of Western Ontario, London, Ont.; Children's Healthcare Canada (Gruenwoldt), Ottawa, Ont.; Department of Pediatrics (MacLeod), Faculty of Medicine, University of British Columbia, Vancouver, BC; Department of Pediatrics (Litalien), University of Montreal, Montréal, Que.
CMAJ. 2022 May 16;194(19):E678-E680. doi: 10.1503/cmaj.220044.